Interleukin-6 Promoter Variants, Prostate Cancer Risk, and Survival
Elizabeth A Tindall, Gianluca Severi, Hoa N Hoang, Melissa C Southey, Dallas R English, John L Hopper, Graham G Giles, Vanessa M Hayes
The Prostate | WILEY-BLACKWELL | Published : 2012
Awarded by National Health and Medical Research Council
Grant sponsor: National Health and Medical Research Council; Grant numbers: 396407, 504700, 504702, 614296; Grant sponsor: Cancer Institute of New South Wales; Grant sponsor: Australian Rotary Health Foundation; Grant sponsor: Prostate Cancer Foundation Australia.This study was supported by grants from the National Health and Medical Research Council (project grants #396407, #504700, and #504702 and Fellowships to E. A. T., M. S. C., and J.L.H.), Cancer Institute of New South Wales Grant (to V. M. H.) and Fellowships (to E. A. T. and V. M. H.), and an Australian Rotary Health Fellowship (to E. A. T.). Infrastructure support was provided from the Children's Cancer Institute Australia, The Cancer Council Victoria and The University of Melbourne. The Australian Prostate Cancer BioResource is supported by an Enabling Grant from the NHMRC (#614296). We are grateful to the study participants, as well as the many urologists, nurses, and pathologists who kindly facilitated in the recruitment and collection of patient information and pathology reports. We would also like to thank the Australian Prostate Cancer BioResource (APCB, http://www.apccbioresource.org.au/) for providing the prostate tissue samples.